Essex Property Trust lands Morgan Stanley target lift, shares in analyst focus
25.06.2026 - 21:52:35 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 21:52.
Essex Property Trust (US29717P1049) sits back in Wall Street’s crosshairs after a fresh research move. Morgan Stanley has adjusted its price target on the NYSE-listed apartment REIT to 302 US dollars from 293 dollars while maintaining an Equalweight rating, according to a MarketScreener summary of the broker note published on June 25, 2026. The MarketScreener report on the Morgan Stanley update
What Morgan Stanley signals
The new 302 dollar target from Morgan Stanley implies modest upside versus a recent ESS share price around the high 280s, and the Equalweight stance underscores a balanced risk-reward view for the S&P 500 constituent. MarketScreener’s broker overview also highlights a June 18 move by Scotiabank, which raised its target to 290 dollars from 282 dollars and reiterated a Sector Outperform rating on Essex Property Trust.
Consensus data on the same page place the average analyst target for ESS shares at roughly 287 dollars, suggesting Morgan Stanley’s new objective now stands slightly above the street mean. Mboum’s snapshot of ESS lists an aggregated price target of about 285.89 dollars and flags a broadly cautious stance with the consensus recommendation skewed toward Sell, underlining how divided views on West Coast multifamily REITs remain.
How the Essex consensus lines up
While individual broker ratings differ, the overall picture is one of restrained optimism around Essex Property Trust’s earnings power and balance sheet. The MarketScreener profile for ESS shows a mix of Buy, Hold and Sell ratings clustered around that mid-280s average target range, with both Morgan Stanley and Scotiabank now at or above 290 dollars on their updated views. The broker table on MarketScreener underlines that range.
Mboum’s ESS overview adds further color with a trailing price-to-earnings ratio around 25 and a beta near 0.72, marking Essex as a relatively lower-volatility REIT compared with the broader equity market. The Mboum data page also notes shares outstanding of about 64 million, giving investors a sense of the REIT’s scale alongside a market capitalization in the high-teens billion dollar range based on recent prices.
All news and analysis on the Essex Property Trust shares
Track past ad-hoc releases, analyst moves and price data for ESS in one place on ad-hoc-news.de or visit the company’s own investor relations pages for primary documents.
How Essex makes its money
Essex Property Trust generates nearly all of its revenue from owning, operating and developing multifamily apartment communities in supply-constrained West Coast markets such as coastal California and the Seattle metropolitan area. According to a financial data profile summarizing its latest annual report, the REIT held interests in roughly 252 apartment complexes with about 61,997 units plus three commercial office buildings totaling 283,000 square feet as of December 31, 2023. The financialdata.net company overview describes this concentration on high-barrier-to-entry urban and suburban locations.
Where the shares trade today
On June 25, 2026 at 13:53 (UTC+8), Essex Property Trust shares (US29717P1049) traded on the NYSE at 284.89 US dollars, according to the real-time quote page at Gate.com, which also showed a 1.15 percent gain over the previous close, a 52-week range of 239.78 to 288.31 dollars and an indicated market capitalization of about 17.63 billion dollars at that price. The Gate.com ESS quote
Key data on the Essex Property Trust shares
- Company: Essex Property Trust, Inc.
- ISIN: US29717P1049
- WKN: 888282
- Ticker: ESS
- Trading venue: NYSE
- Price (as of 2026-06-25, 13:53): 284.89 USD
- Market cap: 17.63 billion USD (as of 2026-06-25)
- Sector / industry: Real Estate Investment Trusts (Residential)
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Every investment decision in listed securities should be based on individual research or professional advice.
